ESC 365 - DOACs or warfarin use in morbidly obese patients (BMI > 40 kg/m2) on anticoagulant therapy? : a systematic review and meta-analysis

Back

ESC Professional Premium Access

DOACs or warfarin use in morbidly obese patients (BMI > 40 kg/m2) on anticoagulant therapy? : a systematic review and meta-analysis

Session: Risk factors: obesity (1)

Topic: Obesity

Speaker: Doctor M. Sagris (Athens, GR)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Marios Sagris

Hippokration General Hospital, Athens (Greece)

0 follower

5 more presentations in this session

Epicardial fat is associated with adverse ventricular remodeling and diastolic dysfunction in women with ischemia but no obstructive coronary artery disease

Speaker: Miss S. Zamani (Arlington, US)

Association between body mass index and outcomes in heart failure across the ejection fraction spectrum: data from the Swedish Heart Failure Registry

Speaker: Doctor G. Ferrannini (Stockholm, SE)

Five-year changes in weight and risk of atrial fibrillation in women and men from the Danish diet, cancer, and health cohort

Speaker: Ms T. Frederiksen (Aarhus, DK)

Prevalence of SELECT-eligibility and incidence of 5-year major adverse cardiovascular outcomes in non-diabetic patients with myocardial infarction

Speaker: Professor M. Maeng (Aarhus, DK)

Effect of diabetes duration on subclinical target organ damage in young diabetic adults with type 1 diabetes mellitus

Speaker: Doctor E. Kowalczyk (Lodz, PL)

Access the full session

Risk factors: obesity (1)

Speakers: Doctor M. Sagris, Miss S. Zamani, Doctor G. Ferrannini, Ms T. Frederiksen, Professor M. Maeng...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

DOACs or warfarin use in morbidly obese patients (BMI > 40 kg/m2) on anticoagulant therapy? : a systematic review and meta-analysis

About the speaker

Doctor Marios Sagris

5 more presentations in this session

Epicardial fat is associated with adverse ventricular remodeling and diastolic dysfunction in women with ischemia but no obstructive coronary artery disease

Association between body mass index and outcomes in heart failure across the ejection fraction spectrum: data from the Swedish Heart Failure Registry

Five-year changes in weight and risk of atrial fibrillation in women and men from the Danish diet, cancer, and health cohort

Prevalence of SELECT-eligibility and incidence of 5-year major adverse cardiovascular outcomes in non-diabetic patients with myocardial infarction

Effect of diabetes duration on subclinical target organ damage in young diabetic adults with type 1 diabetes mellitus

Access the full session

Risk factors: obesity (1)

About the event

ESC Congress 2023

ESC 365 is supported by